Tag: #Ryaltris Nasal Spray
Glenmark’s Ryaltris nasal spray now approved in Europe for the first...
Mumbai, Apr 26 (UNI)Pharma major,Glenmark Pharmaceuticals Limited, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 countries in the European Union.
Ryaltris (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), will shortly be available in Austria, Belgium, Czech Republic, Germany, Denmark, Spain, Finland, France, Ireland, Italy, The Netherlands, Norway, Poland, Romania,Slovakia, Sweden, and the UK.
Glenmark receives marketing approval for Ryaltris Nasal Spray in Russia
Mumbai, Feb 22 (UNI) Pharma Major, Glenmark Pharma on Monday said that its Swiss subsidiary, Glenmark Specialty S.A., received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray - a novel fixed-dose combination nasal spray.
